AIZ vs STRO · P/E 15, rev $12.81B vs rev $62.0M
Assurant Inc (AIZ) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Assurant Inc (AIZ) is a insurance - property & casualty company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported AIZ revenue for 2025-12-31 was $12.81B. Net income was $872.7M. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. AIZ currently screens at market cap $9.98B and trailing P/E 15.4.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
AIZ currently screens at market cap $9.98B and trailing P/E 15.4. STRO currently screens at market cap $470.8M.
Not investment advice. Open the AIZ and STRO stock pages for the full models.
Not investment advice.